This newer chapter is a must-read for any prescribing physician. It covers how genetic variants affect drug metabolism (CYP450 enzymes) and how genetic testing can guide targeted therapies (e.g., HER2 in breast cancer, EGFR in lung cancer).
Today, the book is in its 9th Edition (and soon 10th), edited by Dr. Robert L. Nussbaum, Dr. Roderick R. McInnes, and Dr. Huntington F. Willard. Despite the change in editors, the "Thompson" name has been preserved as a mark of quality and authority. Hence, when professionals search for , they are explicitly looking for that unique blend of basic science and bedside application.
In conclusion, Genetica Medica Thompson has revolutionized our understanding of genetic diseases and their treatment. The contributions of Thompson and other medical geneticists have far-reaching implications for modern medicine, from personalized medicine to targeted therapies. As the field continues to evolve, we can expect to see new and innovative approaches to the diagnosis, treatment, and prevention of genetic diseases. Ultimately, the work of medical geneticists like Thompson will continue to improve human health and well-being. genetica medica thompson
Why is it so popular in Italy?
For nearly 60 years, has been a foundational textbook for medical students, genetic counselors, and health professionals. Now in its 9th edition (released in 2023), the text continues to bridge the gap between abstract molecular theory and real-world clinical practice. Key Features and Content This newer chapter is a must-read for any
| Book | Best for | |------|----------| | | Integrated clinical + molecular overview (the middle ground) | | Emery’s Elements of Medical Genetics | Shorter, more clinically oriented, easier for rotations | | Nussbaum’s Genetics in Medicine | Dense molecular focus, less clinical context | | Online Mendelian Inheritance in Man (OMIM) | Deep reference, not a textbook |
The book is structured to guide readers from core biological concepts to complex medical applications: Robert L
As long as medicine moves toward personalized treatment, the core principles taught in will remain relevant. The technology will change (faster sequencing, cheaper tests), but the concepts of inheritance, mutation, and gene expression are eternal.